Publications by authors named "Dewe Walthere"

Claim this Profile
H
Hamster neogenin, a host-cell protein contained in a respiratory syncytial virus candidate vaccine, induces antibody responses in rabbits but not in clinical trial participants.
Ann-Muriel Steff, Chanel Cadieux-Dion, Gaël de Lannoy, Maria Key Prato, Xavier Czeszak

Hum Vaccin Immunother· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring drug solubility in fasted human intestinal fluid aspirates: Impact of inter-individual variability, sampling site and dilution.
Mariangeles Pérez de la Cruz-Moreno, Consuelo Montejo, Antonio Aguilar-Ros, Walthère Dewe, Benoît Beck

Int J Pharm· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Persistence of Cell-Mediated and Humoral Responses to A(H1N1)pdm09 Influenza Virus Vaccines and the Role of the AS03 Adjuvant System in Adults during Two Randomized Controlled Trials.
Robbert G van der Most, Frédéric Clément, Julie Willekens, Walthère Dewé, Karl Walravens

Clin Vaccine Immunol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant.
Joanne M Langley, Naresh Aggarwal, Azhar Toma, Scott A Halperin, Shelly A McNeil, Walthere Dewé

J Infect Dis· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-criteria decision making approach to identify a vaccine formulation.
Walthère Dewé, Christelle Durand, Sandie Marion, Lidia Oostvogels, Jeanne-Marie Devaster

J Biopharm Stat· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis.
Guillermo M Ruiz-Palacios, Geert Leroux-Roels, Jiri Beran, Jeanne-Marie Devaster, Meral Esen

Hum Vaccin Immunother· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of potential immunogenicity differences between Pandemrix™ and Arepanrix™.
Quentin Canelle, Walthère Dewé, Bruce L Innis, Robbert van der Most

Hum Vaccin Immunother· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influenza vaccine efficacy trials: a simulation approach to understand failures from the past.
Anne Benoit, Catherine Legrand, Walthère Dewé

Pharm Stat· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: pooled analysis of 28 clinical trials.
David W Vaughn, Harry Seifert, Anne Hepburn, Walthere Dewe, Ping Li

Hum Vaccin Immunother· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza Disease.
Anne Benoit, Jiri Beran, Jeanne-Marie Devaster, Meral Esen, Odile Launay

Open Forum Infect Dis· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: a phase III, randomized trial.
Juan Carlos Tinoco, Noris Pavia-Ruz, Aurelio Cruz-Valdez, Carlos Aranza Doniz, Vijayalakshmi Chandrasekaran

Vaccine· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children.
Joanne M Langley, Alfonso Carmona Martinez, Archana Chatterjee, Scott A Halperin, Shelly McNeil

J Infect Dis· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial.
Hans C Rümke, Jan Hendrik Richardus, Lars Rombo, Karlis Pauksens, Georg Plaßmann

BMC Infect Dis· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing vaccine efficacy in influenza clinical trials: challenges and difficulties.
Walthere Dewe, Anne Benoit, Catherine Legrand

Expert Rev Clin Pharmacol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults.
Jiří Beran, Mathieu Peeters, Walthère Dewé, Jolana Raupachová, Lenka Hobzová

BMC Infect Dis· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect on cellular and humoral immune responses of the AS03 adjuvant system in an A/H1N1/2009 influenza virus vaccine administered to adults during two randomized controlled trials.
François Roman, Frédéric Clément, Walthère Dewé, Karl Walravens, Cathy Maes

Clin Vaccine Immunol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase III evaluation of immunogenicity and safety of two trivalent inactivated seasonal influenza vaccines in US children.
Roger Baxter, Robert Jeanfreau, Stanley L Block, Mark Blatter, Michael Pichichero

Pediatr Infect Dis J· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of statistical methodologies used to compare (bio)assays.
Walthère Dewé

J Chromatogr B Analyt Technol Biomed Life Sci· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-month compliance with antidepressant medication in the treatment of major depressive disorder.
Koen Demyttenaere, Albert Adelin, Mesters Patrick, Dewé Walthère, De Bruyckere Katrien

Int Clin Psychopharmacol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using tolerance intervals in pre-study validation of analytical methods to predict in-study results. The fit-for-future-purpose concept.
Eric Rozet, Cédric Hubert, Attilio Ceccato, Walthère Dewé, Eric Ziemons

J Chromatogr A· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partial within-animal calibration: a new calibration approach in lead optimisation high-throughput bioanalysis.
Walthère Dewé, Michaël De Smet, Nathalie Evrard, Benoit Culot, Marc Lastelle

J Chromatogr B Analyt Technol Biomed Life Sci· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What happens with adverse events during 6 months of treatment with selective serotonin reuptake inhibitors?
Koen Demyttenaere, Adelin Albert, Patrick Mesters, Walthère Dewé, Katrien De Bruyckere

J Clin Psychiatry· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of the nature of the electrolyte on the chiral separation of basic compounds in nonaqueous capillary electrophoresis using heptakis(2,3-di-O-methyl-6-O-sulfo)-beta-cyclodextrin.
Anne-Catherine Servais, Marianne Fillet, Patrice Chiap, Walthère Dewé, Philippe Hubert

J Chromatogr A· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New advances in method validation and measurement uncertainty aimed at improving the quality of chemical data.
Max Feinberg, Bruno Boulanger, Walthère Dewé, Philippe Hubert

Anal Bioanal Chem· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis